Search

Search Constraints

You searched for: Author/Creator Rammensee, Hans-Georg

Search Results

1. A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer. Issue 1 (15th November 2019)

4. Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer. Issue 4 (1st May 2016)

5. Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer. Issue 4 (May 2016)

6. Corrigendum to "New vaccination strategies in liver cancer" [Cytokine Growth Factor Rev. 36 (2017) 125–129]. (April 2019)

7. Disulfide-stabilized recombinant MHC class I molecules allow the generation of peptide-receptive MHC tetramers. (October 2022)

9. EXTH-48. NOVEL COMBINATION THERAPY IN PRECLINICAL GLIOMA MODELS USING THE CELL CYCLE STABILIZING COMPOUND ARGYRIN F AND CHECKPOINT INHIBITION. (12th November 2021)

10. Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers. Issue 8 (3rd August 2018)